Stock PURE PURE BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News PURE Bioscience, Inc.

Equities

PURE

US74621T2096

Delayed OTC Markets
Other stock markets
 16:45:16 27/06/2024 BST 		5-day change 1st Jan Change
0.0799 USD +30.98% Intraday chart for PURE Bioscience, Inc. +6.53% -38.40%
05-06 PURE Bioscience Appoints Darin Zehr to Board of Directors CI
03-22 PURE Bioscience, Inc. announced that it has received $3 million in funding CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
PURE Bioscience Announces an International Supply and License Agreement with AgroVet Alliance
BU
PURE Bioscience Reports Fiscal Third Quarter 2024 Financial Results
BU
PURE Bioscience Appoints Darin Zehr to Board of Directors
BU
PURE Bioscience Appoints Darin Zehr to Board of Directors
CI
PURE Bioscience, Inc. announced that it has received $3 million in funding
CI
PURE Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024
CI
PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results
BU
PURE Bioscience, Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023
CI
PURE Bioscience Reports Fiscal First Quarter 2024 Financial Results
BU
PURE Bioscience, Inc. Reports Earnings Results for the Full Year Ended July 31, 2023
CI
PURE Bioscience Reports Fiscal 2023 Financial Results
BU
PURE Bioscience to unveil “PURE Genius” Food Safety Program at the Annual International Association for Food Protection Meeting
BU
PURE Bioscience, Inc. announced that it has received $1.8 million in funding
CI
PURE Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023
CI
PURE Bioscience Reports Fiscal 2023 Third Quarter And Nine-Month Financial Results
BU
PURE BIOSCIENCE, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
Pure Bioscience, Inc. Announces CEO Changes
CI
Pure Bioscience, Inc. Announces Management Changes
CI
PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results
AQ
PURE BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PURE Stock
  4. News PURE Bioscience, Inc.